Rasha A. Khallaf

926 total citations
26 papers, 735 citations indexed

About

Rasha A. Khallaf is a scholar working on Pharmaceutical Science, Public Health, Environmental and Occupational Health and Food Science. According to data from OpenAlex, Rasha A. Khallaf has authored 26 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmaceutical Science, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Food Science. Recurrent topics in Rasha A. Khallaf's work include Advancements in Transdermal Drug Delivery (15 papers), Advanced Drug Delivery Systems (14 papers) and Ocular Surface and Contact Lens (6 papers). Rasha A. Khallaf is often cited by papers focused on Advancements in Transdermal Drug Delivery (15 papers), Advanced Drug Delivery Systems (14 papers) and Ocular Surface and Contact Lens (6 papers). Rasha A. Khallaf collaborates with scholars based in Egypt, Saudi Arabia and India. Rasha A. Khallaf's co-authors include Heba F. Salem, Khaled M. Hosny, Ahmed Abdelbary, Heba M. Aboud, Ossama M. Sayed, Amal M. Sindi, Waleed Y. Rizg, Ahmed Mahmoud Abdelhaleem Ali, Nabil A. Alhakamy and Jelan A. Abdel-Aleem and has published in prestigious journals such as Life Sciences, Journal of Pharmaceutical Sciences and International Journal of Nanomedicine.

In The Last Decade

Rasha A. Khallaf

26 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rasha A. Khallaf Egypt 18 452 117 117 113 76 26 735
Veintramuthu Sankar India 14 373 0.8× 134 1.1× 92 0.8× 125 1.1× 75 1.0× 49 699
Shefaat Ullah Shah Pakistan 18 397 0.9× 113 1.0× 81 0.7× 165 1.5× 44 0.6× 52 746
Sally A. El‐Zahaby Egypt 15 280 0.6× 176 1.5× 70 0.6× 100 0.9× 61 0.8× 34 687
Mireia Mallandrich Spain 17 430 1.0× 119 1.0× 101 0.9× 129 1.1× 122 1.6× 60 848
Shadeed Gad Egypt 15 408 0.9× 127 1.1× 82 0.7× 90 0.8× 63 0.8× 71 624
Alia Badawi Egypt 16 536 1.2× 141 1.2× 85 0.7× 103 0.9× 115 1.5× 41 802
Brice Moulari France 16 350 0.8× 181 1.5× 105 0.9× 195 1.7× 116 1.5× 33 925
Rasha M. Kharshoum Egypt 19 563 1.2× 225 1.9× 71 0.6× 102 0.9× 110 1.4× 31 857
Vikas Bali India 14 571 1.3× 155 1.3× 147 1.3× 90 0.8× 90 1.2× 18 856
Samah Hamed Almurisi Malaysia 11 473 1.0× 134 1.1× 56 0.5× 95 0.8× 135 1.8× 20 740

Countries citing papers authored by Rasha A. Khallaf

Since Specialization
Citations

This map shows the geographic impact of Rasha A. Khallaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rasha A. Khallaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rasha A. Khallaf more than expected).

Fields of papers citing papers by Rasha A. Khallaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rasha A. Khallaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rasha A. Khallaf. The network helps show where Rasha A. Khallaf may publish in the future.

Co-authorship network of co-authors of Rasha A. Khallaf

This figure shows the co-authorship network connecting the top 25 collaborators of Rasha A. Khallaf. A scholar is included among the top collaborators of Rasha A. Khallaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rasha A. Khallaf. Rasha A. Khallaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bukhary, Haitham A., Khaled M. Hosny, Waleed Y. Rizg, et al.. (2024). Development, optimization, in-vitro, and in-vivo evaluation of chitosan-inlayed nano-spanlastics encompassing lercanidipine HCl for enhancement of bioavailability. Journal of Drug Delivery Science and Technology. 96. 105677–105677. 2 indexed citations
4.
Salem, Heba F., et al.. (2022). Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design. Journal of Pharmaceutical Sciences. 112(2). 544–561. 14 indexed citations
5.
Salem, Heba F., et al.. (2022). Glycerosomal thermosensitive in situ gel of duloxetine HCl as a novel nanoplatform for rectal delivery: in vitro optimization and in vivo appraisal. Drug Delivery and Translational Research. 12(12). 3083–3103. 24 indexed citations
7.
Rizg, Waleed Y., Khaled M. Hosny, Abdulmohsin J. Alamoudi, et al.. (2021). Preparation and Optimization of Garlic Oil/Apple Cider Vinegar Nanoemulsion Loaded with Minoxidil to Treat Alopecia. Pharmaceutics. 13(12). 2150–2150. 20 indexed citations
8.
Hosny, Khaled M., Hani Z. Asfour, Waleed Y. Rizg, et al.. (2021). Formulation, Optimization, and Evaluation of Oregano Oil Nanoemulsions for the Treatment of Infections Due to Oral Microbiota. International Journal of Nanomedicine. Volume 16. 5465–5478. 23 indexed citations
9.
Ali, Sarah A., et al.. (2021). Oral gel loaded by ethotransfersomes of antifungal drug for oral thrush: Preparation, characterization, and assessment of antifungal activity. Journal of Drug Delivery Science and Technology. 66. 102841–102841. 10 indexed citations
10.
Hosny, Khaled M., Amal M. Sindi, Hala M. Alkhalidi, et al.. (2021). Development of omega-3 loxoprofen-loaded nanoemulsion to limit the side effect associated with NSAIDs in treatment of tooth pain. Drug Delivery. 28(1). 741–751. 23 indexed citations
12.
Hosny, Khaled M., Nabil A. Alhakamy, Amal M. Sindi, & Rasha A. Khallaf. (2020). Coconut Oil Nanoemulsion Loaded with a Statin Hypolipidemic Drug for Management of Burns: Formulation and In Vivo Evaluation. Pharmaceutics. 12(11). 1061–1061. 41 indexed citations
13.
Salem, Heba F., et al.. (2019). A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using Box-Benkhen design, in vitro and in vivo characterization. Drug Delivery and Translational Research. 10(1). 227–240. 36 indexed citations
14.
Hosny, Khaled M., Hibah M. Aldawsari, Amal M. Sindi, et al.. (2019). Preparation, Optimization, and Evaluation of Hyaluronic Acid-Based Hydrogel Loaded with Miconazole Self-Nanoemulsion for the Treatment of Oral Thrush. AAPS PharmSciTech. 20(7). 297–297. 59 indexed citations
15.
Khallaf, Rasha A., Heba M. Aboud, & Ossama M. Sayed. (2019). Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, andin vivoevaluation. Journal of Liposome Research. 30(2). 163–173. 72 indexed citations
16.
Abou‐Taleb, Heba A., Rasha A. Khallaf, & Jelan A. Abdel-Aleem. (2018). Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation. Drug Design Development and Therapy. Volume 12. 3501–3516. 44 indexed citations
17.
Alkhalidi, Hala M., Ghada H. Naguib, Mallesh Kurakula, et al.. (2018). In vitro and preclinical assessment of factorial design based nanoethosomal transdermal film formulation of mefenamic acid to overcome barriers to its use in relieving pain and inflammation. Journal of Drug Delivery Science and Technology. 48. 450–456. 18 indexed citations
18.
Abdelbary, Ahmed, et al.. (2016). Niosomal 5-Flourouracil gel for effective treatment of skin cancer; In-vitro and In-vivo evaluation. International Journal of Phytomedicine. 7(4). 223–232. 5 indexed citations
19.
Khallaf, Rasha A., Heba F. Salem, & Ahmed Abdelbary. (2016). 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment. Drug Delivery. 23(9). 3452–3460. 85 indexed citations
20.
Salem, Heba F., et al.. (2016). Mucoadhesive niosomalin situgel for ocular tissue targeting:in vitroandin vivoevaluation of lomefloxacin hydrochloride. Pharmaceutical Development and Technology. 22(3). 409–417. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026